Table 1.
Comparison of the baseline characteristics between the patients with CKD and control patients with essential hypertension (EH).
| CKD (n = 48) | EH (n = 27) | P value | |
|---|---|---|---|
| Age (years) | 60 ± 12 | 55.5 ± 9.5 | 0.072 |
| Male sex | 75% (n = 36) | 74% (n = 20) | 0.94 |
| DM nephropathy | 62% (n = 30) | NA | |
| eGFR (mL/min/1.73 m2) | 30.2 ± 11 | 94.4 ± 11.1 | <0.001 |
| LVMI | 81.2 (70.2–97.6) | 86 (71.6–99.6) | 0.419 |
| Systolic BP (mmHg) | 148.8 ± 22.9 | 152.29 ± 19.9 | 0.48 |
| Diastolic BP | 81.8 ± 12 | 94.4 ± 11.1 | <0.001 |
| Phosphate (mmol/L) | 1.2 ± 0.2 | 0.99 ± 0..22 | <0.001 |
| Vitamin D (ng/mL) | 13 (5–20) | 20.5 (14–26.8) | 0.004 |
| FGF-23 (RU/mL) | 237.9 (109.6–393.3) | 12.5 (1.5–35.9) | <0.001 |
| PTH (pg/mL) | 14.5 (6.7–21.6) | 5.7 (4.8–7.3) | <0.001 |
| Calcium (mmol/L) | 2.38 ± 0.1 | 2.4 ± 0.07 | 0.096 |
| Ur PRC (mg/mmol) | 82.5 (19.75–218) | NA |